20/20 GENESYSTEMS, INC.

Company Information
Address 9430 Key West Ave.
ROCKVILLE, MD, 20850-3324

http://www.2020gene.com

Information

DUNS: 136134686

# of Employees: 20


Ownership Information

Hubzone Owned: N

Socially and Economically Disadvantaged: N

Woman Owned: N



Award Charts




Award Listing

  1. IGF::OT::IGF RandD- MEDICAL: BIOMEDICAL (BASIC RESEARCH)

    Amount: $749,959.00

    Not Available

    SBIRPhase II2014Department of Health and Human Services
  2. A COMPANION DIAGNOSTIC FOR PROGNOSIS OF KIDNEY CANCER

    Amount: $199,597.00

    This contract was awarded by the National Cancer Institute's Small Business Innovative Research (SBIR) and Small Business Technology Transfer (STTR) Program under the funding opportunity "Contract Top ...

    SBIRPhase I2010Department of Health and Human Services
  3. PredicTOR: predicting patient response to mTOR pathway inhibitors prior to treatm

    Amount: $2,750,000.00

    DESCRIPTION (provided by applicant): The promise of personalized medicine relies on the development of diagnostic tests to categorize patients within small cohorts who will benefit from specific treat ...

    SBIRPhase II2010Department of Health and Human Services
  4. Autoantibody Profiling for Serological Detection of Head and Neck Cancer

    Amount: $217,801.00

    DESCRIPTION (provided by applicant): SBIR grant support is being sought by 20/20 GeneSystems, Inc. (20/20), a small biotech company, to help us advance what we believe will become the first blood test ...

    SBIRPhase I2009Department of Health and Human Services
  5. Profiling Autoantibodies in Non-small Cell Lung Cancer with Fusion Protein-Peptid

    Amount: $183,927.00

    DESCRIPTION (provided by applicant): Approximately 135,000 new cases of non-small cell lung cancer (NSCLC) are diagnosed each year in the USA, yet only 20%-25% of those patients will be diagnosed at a ...

    SBIRPhase I2009Department of Health and Human Services
  6. Profiling ER, PR, EGFR and HER2 in Breast Cancer Using Multiplex Tissue Immusta

    Amount: $649,622.00

    DESCRIPTION (provided by applicant): We propose to develop a novel method and kit for profiling the expression and activation of signal transduction proteins in breast tumors. The goal is to create ne ...

    SBIRPhase II2008Department of Health and Human Services
  7. Profiling EGFR and Her2 in Breast Cancer using Multiplex Tissue Immunostaining

    Amount: $117,930.00

    DESCRIPTION (provided by applicant): We propose to develop a novel method and kit for profiling the expression and activation of signal transduction proteins in breast tumors. The goal is to create ne ...

    SBIRPhase I2007Department of Health and Human Services
  8. Peptide Array for Profiling of Autoantibodies in Non-small Cell Lung Cancer

    Amount: $165,288.00

    DESCRIPTION (provided by applicant): Approximately 135,000 new cases of non-small cell lung cancer (NSCLC) are diagnosed each year in the USA, yet only 20%-25% of those patients will be diagnosed at a ...

    SBIRPhase I2007Department of Health and Human Services
  9. Auto-antibody profiling of non-small cell lung cancer

    Amount: $177,279.00

    DESCRIPTION (provided by applicant): Tumor markers, measured in peripheral blood, could assist in diagnosis and management of non-small cell lung cancer (NSCLC) and potentially improve historically di ...

    STTRPhase I2006Department of Health and Human Services
  10. Hair Follicle Assay to Monitor Targeted Cancer Therapy

    Amount: $96,489.00

    DESCRIPTION (provided by applicant): Personalized medicine is a new clinical pardigm where a specific cancer therapeutic is prescribed based upon the individual biology of the patient. For example ...

    SBIRPhase I2004Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government